Sisu Global is the future of medical devices in emerging markets. Our flagship autotransfusion device, Hemafuse, provides a cutting-edge alternative to donor blood. Hemafuse can salvage, filter, and recycle a patient's own blood from internal bleeding. Sisu is a women-founded and women-led medical device company that has proven their ability to execute, taking their first product to market on less than 10% of the average cost to take a medical device through regulatory in the US.
CEO and Founder
Carolyn Yarina, CEO & Co-Founder of Sisu Global, is a two-time founder/CEO with a proven track record of execution. She has raised nearly $3M from investors like Camden Partners & Revolution's Rise of the Rest Seed Fund. Carolyn has received awards from Forbes 30 under 30 in Healthcare, Maryland’s Innovator of the Year, and Baltimore’s Top 10 BioHealth CEO and been featured in USA Today, Entrepreneur Magazine, and TEDxMidAtlantic.
Gillian Henker, CTO & Co-Founder of Sisu Global, manages Sisu’s products and technical strategy. She is the primary inventor of Hemafuse and has directed Hemafuse’s development from an idea to fully manufactured, injection-molded device. Gillian previously founded a medical device design firm for Ghana. She has been published in the International Journal of Gynecology and Obstetrics, has presented at the Midwest Biomedical Engineering Career Conference and Appropriate Healthcare Technologies for Developing Countries Seminar in London, and was named Baltimore’s Technologist of the Year.
Gillian Henker, CTO & Co-Founder